GlaxoSmithKline (GSK) Reports Q3 EPS of30.5c; Revs Ease
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of $0.31, versus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
